Kinder Morgan (KMI) came out with quarterly earnings of $0.28 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this oil and natural gas pipeline and storage company would post earnings of $0.35 per share when it actually produced earnings of $0.34, delivering a surprise of -2.86%.Over the last four quarters, the company has not been able to surpass consensus ...

AAR (AIR) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $0.88 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +16.00%. A quarter ago, it was expected that this airplane maintenance company would post earnings of $0.96 per share when it actually produced earnings of $0.99, delivering a surprise of +3.13%.Over the last four quarters, the co ...

Monarch Casino (MCRI) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.03%. A quarter ago, it was expected that this casino operator would post earnings of $1.04 per share when it actually produced earnings of $1.05, delivering a surprise of +0.96%.Over the last four quarters, the ...

Group 1 - Johnson & Johnson reported quarterly earnings of $2.77 per share, exceeding the Zacks Consensus Estimate of $2.66 per share, but down from $2.82 per share a year ago, representing an earnings surprise of +4.14% [1] - The company achieved revenues of $23.74 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.13% and increasing from $22.45 billion year-over-year [2] - Johnson & Johnson has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Group 2 - The stock has gained approximately 7.3% since the beginning of the year, outperforming the S&P 500's gain of 6.2% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to those expectations [4] - The current consensus EPS estimate for the upcoming quarter is $2.75 on revenues of $23.17 billion, and for the current fiscal year, it is $10.64 on revenues of $91.33 billion [7] Group 3 - The Zacks Industry Rank indicates that the Large Cap Pharmaceuticals sector is in the top 26% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this category [8] - Johnson & Johnson currently holds a Zacks Rank 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6]

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.66 per share. This compares to earnings of $2.82 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.14%. A quarter ago, it was expected that this world's biggest maker of health care products would post earnings of $2.57 per share when it actually produced earnings of $2.77, delivering a surprise of +7.78%.Ov ...

Ouster, Inc. (OUST) shares ended the last trading session 14.5% higher at $28.3. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 24.2% gain over the past four weeks.Ouster is benefiting from the accelerating adoption of LiDAR technology across automotive, industrial, robotics, and smart infrastructure sectors.This company is expected to post quarterly loss of $0.48 per share in its upcoming report, which represents ...

The Trade Desk (TTD) shares rallied 6.6% in the last trading session to close at $80.4. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 7.4% gain over the past four weeks.The Trade Desk is benefiting from higher adoption of Connected TV (CTV) amid the convergence of the Internet and television programming. This particular growth driver is fast becoming the focus of the company’s growth strategy.This digital-a ...

Investors might want to bet on Robinhood Markets, Inc. (HOOD) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.Analysts' growing optimism on the earnings prospects of this company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings es ...

Boyd Gaming (BYD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual investors oft ...

Immunovant, Inc. (IMVT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. ...